Survival trends among 1,325 patients with chronic lymphocytic leukemia seen over the past 40 years in Israel

American Journal of Hematology

Volumn 86, Issue 12, 2011, Pages 985-992

  Shvidel, Lev ^a   Braester, Andrei ^b   Bairey, Osnat ^c   Rahimi Levene, Naomi ^c   Klepfish, Abraham ^c   Herishanu, Yair ^c   Shtalrid, Mordechai ^a   Polliack, Aaron ^d,e   Berrebi, Alain ^a,d  

^a HEBREW UNIVERSITY   (Israel)

^b WESTERN GALILEE HOSPITAL   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d Study Group on CLL   (Israel)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BENDAMUSTINE; BETA 2 MICROGLOBULIN; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; PREDNIMUSTINE; PREDNISONE; PROTEIN KINASE ZAP 70; RITUXIMAB; VINCRISTINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DEMOGRAPHY; FEMALE; HUMAN; ISRAEL; LIFE EXPECTANCY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; TREND STUDY;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BETA 2-MICROGLOBULIN; COHORT STUDIES; DATABASES, FACTUAL; EARLY DIAGNOSIS; FEMALE; HUMANS; ISRAEL; LEUKEMIA, LYMPHOID; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 81355148751     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22160     Document Type: Article

References (17)

1. Rozman C, Bosch F, Montserrat E. Chronic lymphocytic leukemia: A changing natural history? Leukemia 1997; 11: 775-778.
2. Molica S, Levato D. What is changing in the natural history of chronic lymphocytic leukemia? Haematologica 2001; 86: 8-12.
3. Abrisqueta P, Pereira A, Rozman C, et al. Improving survival in patients with chronic lymphocytic leukemia (1980-2008): The Hospital Clinic of Barcelona experience. Blood 2009; 114: 2044-2050.
4. Tam CS, O'Brien S, Wierda W, et al. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. Blood 2008; 112: 975-980.
5. Hallek M, Fischer K, Fingerle-Rowson G, et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: A randomised, open-label, phase 3 trial. Lancet 2010; 376: 1164-1174.
6. Brenner H, Gondos A, Pulte D. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood 2008; 111: 4916-4921.
7. Kristinsson SY, Dickman PW, Wilson WH, Caporaso N, Björkholm M, Landgren O. Improved survival in chronic lymphocytic leukemia in the past decade: A population-based study including 11, 179 patients diagnosed between 1973-2003 in Sweden. Haematologica 2009; 94: 1259-1265.
8. Thurmes P, Call T, Slager S, et al. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leuk Lymph 2008; 49: 49-56.
9. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198-206.
10. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990-4997.
11. Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 Guidelines. Blood 2008; 111: 5446-5456.
12. Central Bureau of Statistics, Jerusalem.
13. The French Cooperative Group on Chronic Lymphocytic Leukaemia. Long term results of the CHOP regimen in stage C chronic lymphocytic leukaemia. Br J Haematol 1989; 73: 334-340.
14. Shvidel L, Shtarlid M, Klepfish A, Sigler E, Berrebi A. Epidemiology and ethnic aspects of B cell chronic lymphocytic leukemia in Israel. Leukemia 1998; 12: 1612-1617.
15. Mauro FR, Foa R, Giannarelli D, et al. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: A single institution study of 204 cases. Blood 1999; 94: 448-454.
16. Shanafelt TD, Rabe KG, Kay NE, et al. Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia. Cancer 2010; 116: 4777-4787.
17. Molica S, Levato D, Dattilo A. Natural history of early chronic lymphocytic leukemia. A single institution study with emphasis on the impact of disease-progression on overall survival. Haematologica 1999; 84: 1094-1099.